COMPREHENSIVE ASSESSMENT OF THE MARKET DRUGS FOR TREATMENT OF PNEUMONIA IN PEDIATRICS
The results of present work show that the largest (52%) share of drugs for etiotropic therapy of pneumonia in pediatrics is represented by foreign manufacturers. Asian countries (India (38,45%) and China (6,46%) bring the most contribution into the structure of import. Drugs in form of powders and l...
Saved in:
| Main Authors: | D. D. Siukaeva, O. D. Nemyatyh, I. A. Narkevich, N. I. Pavlenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/531 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01) -
Marketing research of the national antiarrhythmic drugs market
by: T. P. Zarichna, et al.
Published: (2019-08-01) -
Sequential Mycoplasma pneumoniae pneumonia and Chromobacterium violaceum skin abscess in a pediatric patient
by: Weizhen Guo, et al.
Published: (2017-09-01) -
MARKETING STUDIES OF LOCAL MARKET OF DRUGS WHICH ARE APPLIED FOR PREVENTION AND TREATMENT OF ORAL CAVITY DISEASES
by: O. A. Tsarakhov, et al.
Published: (2015-11-01) -
Clinical Efficacy of Azithromycin in the Treatment of Pediatric Mycoplasma pneumoniae Pneumonia and Its Impact on Platelet Count and D-Dimer Levels
by: Cheng Y, et al.
Published: (2024-11-01)